Hostname: page-component-74656f9884-j7cmm Total loading time: 0 Render date: 2026-11-05T17:10:43.209Z Has data issue: false hasContentIssue false
  • English
  • Français

Association of multiple sclerosis with psychiatric disorders and homelessness among veterans in the United States Department of Veterans Affairs healthcare system

Published online by Cambridge University Press:  22 November 2024

Stephanie L. Silveira Open the ORCID record for Stephanie L. Silveira [Opens in a new window] ,
Hind Beydoun  and
Jack Tsai Open the ORCID record for Jack Tsai [Opens in a new window]
Stephanie L. Silveira
Affiliation:
Department of Management, Policy, and Community Health, University of Texas Health Science Center at Houston, Houston, TX, 77030, USA
Hind Beydoun
Affiliation:
Department of Management, Policy, and Community Health, University of Texas Health Science Center at Houston, Houston, TX, 77030, USA National Center on Homelessness among Veterans, U.S. Department of Veterans Affairs, Homeless Programs Office, Washington, DC, 20420, USA
Jack Tsai*
Affiliation:
Department of Management, Policy, and Community Health, University of Texas Health Science Center at Houston, Houston, TX, 77030, USA National Center on Homelessness among Veterans, U.S. Department of Veterans Affairs, Homeless Programs Office, Washington, DC, 20420, USA
*
Corresponding author: Jack Tsai; Email: Jack.Tsai@uth.tmc.edu
Rights & Permissions [Opens in a new window]

Abstract

Objective

To describe and compare the prevalence of psychosocial and psychiatric disorders among veterans with multiple sclerosis (MS) and a propensity-score-matched group of veterans without MS, and to identify sociodemographic and clinical characteristics associated with comorbid psychosocial and psychiatric problems among veterans with MS.

Methods

Data were linked and extracted from the Veterans Affairs (VA) Homeless Operations Management and Evaluation System and the Corporate Data Warehouse. The total sample comprised 27,342 veterans in the VA healthcare system between January 1, 2022, and June 30, 2023, who met eligibility criteria for an MS diagnosis (n=13,671) and 1:1 propensity-score-matched sample of veterans who did not have MS (n=13,671). MS diagnosis, substance use disorder (SUD), mental illness, and homelessness were defined using standard ICD-10 codes. Covariates included sex, age, Charlson Comorbidity Index (CCI), and VA service-connected disability rating.

Results

A higher prevalence of mental illness among veterans with MS (33%) was found compared with those without MS (31%). Multivariable logistic regression models indicated MS was negatively associated with diagnoses of alcohol use disorder, stimulant use disorders, posttraumatic stress disorder, and schizophrenia/schizoaffective disorder but positively associated with diagnoses of cannabis use disorder and major depressive disorder. MS was not significantly related to homelessness. Disparities in psychosocial and psychiatric disorders among veterans with MS are described.

Conclusion

This study provides novel insights regarding rates of homelessness, SUD, and mental illnesses among veterans with MS. Interdisciplinary approaches to identification and management of mental illness, SUD, and homelessness among veterans with MS are critically needed.

Keywords

mental healthsubstance usehomelessnessmultiple sclerosisveteran

Information

Type
Original Research
Information
CNS Spectrums , Volume 29 , Issue 5 , October 2024 , pp. 433 - 440
Creative Commons
This is a work of the US Government and is not subject to copyright protection within the United States. Published by Cambridge University Press.
Copyright
© U.S. Department of Veterans Affairs, 2024.

Introduction

Multiple sclerosis (MS) is an autoimmune disease of the central nervous system (CNS) with multifactorial etiology and is the most prevalent chronic, lifelong, progressive, neurological disease affecting young adults.Reference Abdel Magid, Jin, Culpepper, Nelson and Wallin 1 –Reference Hong, Tang, Ma, Chen, Xie and He 4 There are an estimated 1 million persons with MS living in the United States (U.S.), and higher rates are observed among women compared to men.Reference Wallin, Culpepper and Campbell 5 MS has the potential to cause disability in all major domains of the CNS, with alterations in strength, sensation, cognition, vision, and coordination.Reference Abdel Magid, Jin, Culpepper, Nelson and Wallin 1 –Reference Hoang, Cameron, Gandevia and Lord 3 , Reference LaVela, Prohaska, Furner and Weaver 6 , Reference Mazumder, Murchison, Bourdette and Cameron 7 An MS diagnosis is associated with adverse consequences to quality of life, including physical, cognitive, psychological, and social functioning.Reference Bergmann, Becker and Watts 8 With > 20 partially effective FDA-approved disease-modifying therapies (DMTs), managing MS has grown more complicated over the past 20 years, needing specialty neurology and an interdisciplinary team in addition to a wide range of healthcare providers, including neurologists, nurses, therapists, and social workers.Reference Abdel Magid, Jin, Culpepper, Nelson and Wallin 1 , Reference Lo, Hadjimichael and Vollmer 9

The U.S. Department of Veterans Affairs (VA) has been at the forefront of research activities focused on persons with MS, with approximately 16,000 veterans treated within the VA healthcare system per annum.Reference Nelson, Xie and DuVall 10 For instance, the VA Cooperative Study was the first class 1 therapy trial for MS, investigating military veteran communities in the U.S., including men hospitalized during World War II, Korean Conflict veterans, and later service veterans.Reference Kurtzke 11 A study analyzing data from the North American Research Committee on Multiple Sclerosis (NARCOMS) registry found that the Veteran Healthcare Administration (VHA) system provides better multidisciplinary care, particularly in social work, physical therapy, and urology, whereas treatment patterns for symptomatic therapies follow similar patterns across veterans and nonveterans groups, and veterans within VHA used immunomodulatory agents less frequently than their nonveteran counterparts.Reference Lo, Hadjimichael and Vollmer 9 A study comparing primary survey data for male veterans with MS with secondary data from the 2003 Behavioral Risk Factor Surveillance System (BRFSS) found a higher prevalence of hypercholesterolemia, hypertension, diabetes, coronary heart disease, and stroke among male veterans than nonveterans with MS, and that correlation of chronic diseases among male veterans with MS were similar to general population literature.Reference Lavela, Prohaska, Furner and Weaver 12 Despite its established impact on quality of life, few studies have examined substance use and mental health implications of MS among veteran and nonveteran populations,Reference Abdollahpour, Nedjat, Mansournia, Eckert and Weinstock-Guttman 2 , Reference Bambara, Turner, Williams and Haselkorn 13 –Reference Turner, Williams, Bowen, Kivlahan and Haselkorn 19 and only one study highlighted homelessness as a stressful life event that may be linked to MS.Reference Abdollahpour, Nedjat, Mansournia, Eckert and Weinstock-Guttman 2

Mental illness and substance use disorders (SUDs) are major health research areas in the general U.S. veteran population given these modifiable factors pose the greatest risk for social dysfunction and homelessness among other important functional outcomes.Reference Edens, Kasprow, Tsai and Rosenheck 20 –Reference Tsai, Pietrzak and Szymkowiak 22 It is well established that veterans with disabilities, such as MS, are at a higher risk of homelessness.Reference Fargo, Brignone and Metraux 23 , Reference Tsai and Rosenheck 24 The specific mechanism relating mental illness, SUDs, and homelessness has not been elucidated; however, there is a pressing need to investigate these interactions in subpopulations of veterans who may be at higher risk of homelessness and experience greater rates of mental illness and SUDs. The current study aimed to perform analyses of contemporary national VA administrative data in 2023 to (1) examine the prevalence of homelessness, SUDs, and mental illnesses, among veterans with MS; (2) compare rates of homelessness, SUDs, and mental illnesses among veterans with MS and propensity-score-matched veterans without MS; and (3) identify sociodemographic and clinical characteristics associated with homelessness, SUDs, and mental illnesses among veterans with MS. This information is expected to contribute to epidemiological understanding of how behavioral health disorders are related to MS.

Methods

Study design, data, and participants

Cross-sectional data were extracted from two VA databases, namely, the Homeless Operations Management and Evaluation System (HOMES) and the VA Corporate Data Warehouse (CDW). HOMES is an online data collection system that facilitates the identification of veterans in various states of housing instability and homelessness,Reference Tsai, Kasprow and Rosenheck 25 and the CDW is a national repository of electronic health records comprising data on all inpatient and outpatient encounters from the VHA administrative and clinical systems.Reference Ferguson, Wray and Jacobs 26 , Reference Jones, Gordon and Gabrielian 27 Data extracted from the CDW and HOMES databases consist of patient demographics, medications, diagnoses, procedures, clinical notes, and billing information, including dates and settings of healthcare use.Reference Ferguson, Wray and Jacobs 26 , Reference Swankoski, Reddy, Grembowski, Chang and Wong 28 –Reference Holliday, Smith and Kinney 32 Data management and analyses were performed using Microsoft’s Structured Query Language (SQL) Management Studio (SSMS) version 18 (Redmond, WA), and the SAS Enterprise Guide version 8.3 (SAS Institute, Cary, NC).

The study sample comprised all veterans in the VA healthcare system who were alive between January 1, 2022, and June 30, 2023, and met eligibility criteria defining an MS diagnosis (Cohort 1) and a propensity-score-matched sample of veterans in the VA healthcare system who were alive between January 1, 2022, and June 30, 2023, and did not meet eligibility criteria defining an MS diagnosis (Cohort 2). Propensity-score matching based on sex (Male vs. Female), and age (years), was performed using PSMATCH in SAS. The date of the first VA healthcare system visit identified through linked HOMES and CDW data or first homelessness screen response identified through CDW data, within the study period, was considered the index date. Because veterans may have made multiple contacts with the VHA, we retained the date of their first encounter between January 1, 2022, and December 31, 2022, through HOMES or CDW databases. Using linked HOMES and CDW data, the occurrence of homelessness, SUDs, and mental illnesses within 6 months of a veteran’s index date (i.e., the time period between the index date and 6 months afterward) and within a prespecified period of time (January 1, 2022–June 30, 2023) were defined as the main correlates of MS. Veterans were included in the study if they met the following criteria: 1) utilized the VHA for healthcare; 2) had an index encounter date between January 1, 2022, and December 31, 2022; and 3) were aged between 18 and 99 at their index date. Furthermore, veterans were excluded from the study if they met the following criteria: 1) died prior to June 30, 2023 or 2) had missing data on the measures described below. This project was conducted as part of quality improvement efforts initiated by the National Center on Homelessness among Veterans in VA Central Office and was therefore exempt from the VA institutional review board.

Measures

Multiple sclerosis. We generated two cohorts of veterans with and without MS, by applying a prespecified definition for MS based on multiple sources within the CDW database. If a patient satisfied any of the following criteria, they were considered confirmed cases of MS: 1) had evidence of at least 1 MS ICD-10-CM diagnostic code (multiple sclerosis [G35], other specified demyelinating diseases of the CNS [G37.8], and/or demyelinating diseases of the CNS [G37.9]) identified in the context of an inpatient or an outpatient visit, between January 1, 2022, and June 30, 2023, and within 6 months of their index date; 2) had at least 1 treatment with DMTs for MS from CDW inception date until 6 months of their index date; and/or 3) was service-connected for MS from CDW inception date until 6 months of their index date. This definition was selected based on standard practice at the VHA while taking the published literature into consideration.Reference Abdel Magid, Jin, Culpepper, Nelson and Wallin 1 , Reference Mazumder, Murchison, Bourdette and Cameron 7 , Reference Lo, Hadjimichael and Vollmer 9 –Reference Bambara, Turner, Williams and Haselkorn 13 , Reference Bagnato and Wallin 33 –Reference Wallin, Culpepper and Coffman 41

SUDs. A veteran was identified as having an SUD if they had at least one ICD-10-CM diagnostic code in the context of an inpatient or an outpatient visit that corresponds to alcohol use disorder, opioid use disorder, cannabis use disorder, stimulant use disorder, sedative/hypnotic/anxiolytic use disorder, and hallucinogen use disorder, occurring between January 1, 2022, and June 30, 2023, and within 6 months of their index date (list of ICD-10-CM codes used are listed in Supplement 1).

Mental illness. A veteran was identified as having a mental illness if they had at least one ICD-10-CM diagnostic code in the context of an inpatient or an outpatient visit that corresponds to major depressive disorder (MDD), posttraumatic stress disorder (PTSD), generalized anxiety disorder, bipolar disorder, and schizophrenia/schizoaffective disorder, occurring between January 1, 2022, and June 30, 2023, and within 6 months of their index date (list of ICD-10-CM codes used are listed in Supplement 2).

Homelessness. We identified a record as belonging to a veteran who had experienced homelessness during the time period between January 1, 2022, and June 30, 2023, using linked HOMES and CDW data, using VHA’s operational definition as described elsewhere.Reference Tsai, Szymkowiak and Jutkowitz 42 Specifically, homelessness was identified among outpatient and inpatient records with ICD-10-CM diagnostic code that is descriptive of homelessness (Z59.0), in the presence of outpatient stop codes indicating clinical encounters with outpatient staff in the Grant and Per Diem (GPD) program, the Health Care for Homeless Veterans (HCHV)/Homeless Chronically Mentally Ill (HCMI) program, and/or inpatient stop codes indicating clinical encounters with inpatient staff including the Domiciliary Care for Homeless Veterans (DCHV) program and the Compensated Work Therapy/Transitional Residence (CWT/TR) program, if the veteran had a positive screen on an annual homeless screening clinical reminder (HSCR)—responded “no” to “In the past 2 months, have you been living in stable housing that you own, rent, or stay in as part of a household?” based on CDW data, and/or had evidence of participation in GPD, HCHV/HCMI, DCHV, or CWT/TR based on HOMES data, between January 1, 2022, and June 30, 2023, and within 6 months of their index date.

Covariates. Besides sex (male vs. female), age (years), Charlson Comorbidity Index (CCI), and percent service-connected disability rating, which were considered as candidate variables in propensity-score matching, we also examined the following potential confounders for the hypothesized relationships: race, marital status, combat service, as defined at baseline (i.e. index date). The CCI score was calculated using 17 ICD-10-CM diagnostic codes, as described elsewhere,Reference Sundararajan, Henderson, Perry, Muggivan, Quan and Ghali 43 reflecting the cumulative increase in the likelihood of 1-year mortality due to severity of the selected comorbidities.

Statistical analysis

All statistical analyses were performed using the SAS Enterprise Guide version 8.3 (SAS Institute, Cary, NC), whereby MS status was considered the exposure variable to be examined in relation to multiple outcome variables of interest, namely, homelessness, SUDs, and mental illnesses. First, the prevalence rates of any homelessness, SUD, and mental illness were calculated with their 95% confidence intervals (CIs) among veterans with MS. Second, a propensity-score-matched group of veterans without MS was created to be matched on sex and age with the sample of veterans with MS. Third, bivariate analyses were conducted comparing veterans with MS to propensity-score-matched comparison group of veterans without MS on rates of homelessness, SUDs, and mental illnesses. Fourth, these bivariate analyses were then followed with multivariable logistic regression analyses to examine whether veterans with MS had higher rates of homelessness, SUDs, and mental illnesses than other veterans without MS after adjusting for confounders. Fifth, among the sample of veterans with MS, a series of multivariable logistic regression models were constructed to identify sociodemographic and clinical characteristics associated with any homelessness, SUDs, and mental illness. We calculated propensity scores or predicted probabilities of MS vs. No MS for each veteran based on a set of relevant characteristics using a two-step procedure: (1) MS vs. no MS was modeled as the outcome variable in a multiple logistic regression model including as predictor variables a selected group of covariates that were identified as key confounders of the exposure-outcome association; (2) predicted probabilities of MS vs. No MS (“propensity scores”) were used for the purpose of matching MS and non-MS exposure groups and these matched subjects were later used within regression models that examined the relationship of MS vs. no MS status with homelessness, SUDs, and mental illnesses, whereby covariates were added if needed. The PSMATCH procedure was applied for the purpose of 1:1 matching, using the greedy nearest neighbor method with caliper specified at 0.50. Two-sided statistical tests were performed at α=0.05.

Results

A total of 6,861,414 (18,569 MS and 6,842,845 non-MS) veterans sought VHA services between January 1, 2022, and December 31, 2022, of which 4,212,580 (13,671 MS and 4,198,909 non-MS) remained in the study sample after all eligibility criteria were applied. Using propensity scores generated through propensity-score matching on sex and age, each veteran with MS was 1:1 matched to another veteran from the pool of non-MS veterans, resulting in a total sample of 27,342 veterans, that is, 13,671 MS and 13,671 non-MS veterans (Figure 1). The sociodemographic and clinical characteristics of veterans diagnosed with MS and propensity-score-matched veterans not diagnosed with MS are displayed in Table 1. As expected, the distribution by sex and age was similar among the propensity-score-matched groups. By contrast, MS and non-MS groups of veterans differed with more non-Hispanic white individuals, more married individuals, higher disability ratings and CCI, and fewer individuals with combat service exposure among the MS group.

Figure 1.

Study flowchart.

Table 1.

Sociodemographic and Clinical Characteristics of U.S. Veterans Diagnosed with Multiple Sclerosis (MS) and Propensity-Score-Matched U.S. Veterans Not Diagnosed with MS—Veterans Health Administration (January 1, 2022-December 31, 2022)

Differences in prevalence rates of homelessness, diagnosed SUD, and mental illnesses between veterans diagnosed with MS and propensity-score-matched veterans not diagnosed with MS are shown in Table 2 and depicted in Figure 2. Specifically, there was a higher prevalence of mental illness among veterans with MS (32.8%) compared with propensity-score-matched veterans without MS (30.5%). There was a higher prevalence of both homelessness and SUDs among propensity-score-matched veterans without MS (3.1% and 5.7%, respectively) compared with veterans with MS (2.7% and 4.5%, respectively).

Figure 2.

Prevalence (95% confidence interval) of homelessness, substance use disorders, and mental illness, among U.S. veterans diagnosed with multiple sclerosis and propensity-score-matched U.S. veterans not diagnosed with multiple sclerosis—Veterans Health Administration (January 1, 2022–December 22, 2022)

Table 2.

Differences in Prevalence of Homelessness, Substance Use Disorders, and Mental Illnesses between U.S. Veterans Diagnosed with Multiple Sclerosis (MS) and Propensity-Score-Matched U.S. Veterans Not Diagnosed with MS—Veterans Health Administration (January 1, 2022-December 31, 2022)

* Based on propensity-score-matched samples whereby logistic regression models were constructed separately for each of the selected outcome variables in relation to multiple sclerosis status as the exposure variable, controlling for covariates (race, marital status, combat service, percent service-connected disability rating, and Charlson’s comorbidity index).

Multivariable logistic regression models were constructed separately for each of the selected outcome variables in relation to MS status as the exposure variable, after adjustment for race, marital status, combat service, percent service-connected disability rating, and CCI. These multivariable analyses suggested that MS was negatively associated with SUD (OR=0.77, 95% CI: 0.69, 0.87), with variation according to type of substance. Specifically, MS was negatively associated with alcohol use (OR=0.59, 95% CI: 0.52, 0.68) and stimulant use (OR=0.57, 95% CI: 0.43, 0.78) disorders but positively associated with cannabis use disorder (OR=1.20, 95% CI: 0.99, 1.45). Similarly, MS was positively associated with MDD (OR=1.29, 95% CI: 1.22, 1.38) but negatively associated with PTSD (OR=0.69, 95% CI: 0.65, 0.74) and schizophrenia/schizoaffective disorder (OR=0.61, 95% CI: (0.49, 0.77). Conversely, MS was not significantly related to homelessness, after adjustment for covariates.

Table 3 presents multiple logistic regression models for sociodemographic and clinical correlates of the prevalence of homelessness, SUD, and mental illnesses among veterans with MS. Results of these multivariable analyses suggested no sex differences in homelessness among veterans with MS, whereas SUDs were more frequent among male veterans, and mental illnesses were more frequent among female veterans. Furthermore, homelessness, SUDs, and mental illnesses were inversely related to age. Compared to non-Hispanic white veterans, those who identified themselves as non-Hispanic black or had missing data on race were more likely to have experienced homelessness, while those who identified themselves as Hispanic, mixed/other race, were more likely to be diagnosed with mental illnesses. Homelessness, SUDs, and mental illnesses were more frequently observed among single/never married and separated/divorced veterans as compared to married veterans, whereas widowed veterans were more likely than married veterans to be diagnosed with mental illnesses. A positive association was observed between combat service, disability rating, and mental illnesses, whereas the CCI score was positively associated with both SUDs and mental illnesses, among veterans with MS.

Table 3.

Multiple Logistic Regression Models for Sociodemographic and Clinical Correlates of Prevalent Homelessness, Substance Use Disorder, and Mental Illness, among U.S. Veterans Diagnosed with Multiple Sclerosis (MS)—Veterans Health Administration (January 1, 2022–December 31, 2022)

Discussion

Results from this study provide new data and novel insights regarding homelessness, SUDs, and mental illnesses, among veterans with MS, which have been rarely explored in the literature. Perhaps, the most notable finding was the higher prevalence of mental illness among veterans with MS compared with veterans without MS. Characteristics associated with higher rates of mental illnesses among veterans with MS included younger age, unmarried status, Hispanic ethnicity or mixed/other race, combat service, and disability status. These findings highlight an important consideration for clinical teams within the VHA, specifically the need to conduct appropriate screening and referrals among veterans with MS based on nonmodifiable sociodemographic characteristics (i.e., age, marital status, sex, race, combat service, and disability).

There is a strong body of evidence indicating a higher prevalence of psychiatric comorbidity among persons with MS as other studies have found rates of depression 2-5-folds higher than the general population.Reference Marrie, Reingold and Cohen 44 , Reference Inanc and Kaya 45 Our findings align with the ongoing concern about the prevalence of MDD in the MS population that has been associated with greater health services use.Reference Marrie, Walld and Bolton 46 Results from a recent systematic review highlighted the high prevalence of anxiety and depression in particular (more than 20%), but noted a significant gap in the literature regarding studies devoted to other psychiatric comorbidities such as bipolar and SUDs that are of significant clinical relevance.Reference Marrie, Reingold and Cohen 44 The current study addresses this gap in the literature, particularly among veterans with MS, who may be at greater risk of mental illnesses. There are various theorized mechanisms for higher prevalence of psychiatric comorbidities including the impact of MS diagnosis and MS symptoms (e.g., disability status); however, the inflammatory and neurogenerative processes of MS have been strongly associated with depression and bipolar mood disorders.Reference Inanc and Kaya 45 One key takeaway from the evidence regarding mental illness among veterans with MS is a critical need for multidisciplinary diagnosis and treatment approaches.

There was a lower prevalence of alcohol and stimulant use disorders among veterans with MS, but higher rates of cannabis use disorders compared to veterans without MS. Over the past 10 years there has been great interest in the use of cannabis as a second-line symptom management strategy for pain.Reference Gupta, Fellows, Weinstock-Guttman, Hagemeier, Zivadinov and Ramanathan 47 Results from this study are related to other recent research comparing general cannabis use between adults with MS and controls wherein persons with MS are more likely to report recent cannabis use.Reference Gupta, Fellows, Weinstock-Guttman, Hagemeier, Zivadinov and Ramanathan 47 Further research is needed to examine the rates of general cannabis use versus cannabis use disorders in persons with MS. Another pain management treatment of interest among veterans globally is opioids.Reference Sandbrink, Murphy and Johansson 48 One previous study among veterans with MS indicated over a 3-year period (2015-2017) chronic opioid use declined.Reference Turner, Arewasikporn and Hawkins 18 Low rates of opioid use in the current cohort are a positive indication; however, there is a need for widely available and effective treatment strategies for chronic pain among persons with MS given the limited research on cannabis.

There was no significant difference in the prevalence of homelessness between veterans with and without MS. However, there was an indication of non-Hispanic black veterans, regardless of MS diagnosis, being at high risk for homelessness which has been well-documented in both the general and veteran populations.Reference Tsai, Pietrzak and Szymkowiak 22 , Reference Fusaro, Levy and Shaefer 49 , Reference Montgomery, Szymkowiak and Tsai 50 Among veterans, race is associated with greater housing instability in general and the use of VHA homeless programs in particular.Reference Tsai, Pietrzak and Szymkowiak 22 , Reference Montgomery, Szymkowiak and Tsai 50 Additionally, there are well-documented health disparities among minority populations with MS, particularly non-Hispanic blacks, which lead to disproportionate access to first-line DMTs and specialty care.Reference Montgomery, Szymkowiak and Tsai 51 Such compounding disparities can have significant implications for patient outcomes and quality of life that must be addressed within the VHA system through rigorous screening and referral mechanisms to support marginalized persons with MS.

The current study has several notable limitations. There are likely distinct differences between veterans with MS and the general MS population; as such, results from the current study may not be generalizable to all persons with MS. This study highlights the pressing need for further research among black and ethnic-minority populations with MS in general in the U.S. and globally given health disparities associated with social determinants of health.Reference Montgomery, Szymkowiak and Tsai 51 Specifically, culturally tailored resources may be needed to mitigate the risk of psychiatric disorders and homelessness. The cross-sectional nature of data collection limits the assessment of directionality of associations examined in the current study. Additionally, there was a low prevalence of homelessness in the current sample; however, there are many veterans with MS who experience homelessness and housing instability that warrant focal research on their needs to guide appropriate healthcare resources and interventions.

Conclusion

In conclusion, veterans with MS were more likely to have some psychiatric disorders than veterans without MS but there was no difference in rates of homelessness. Certain veterans with MS such as those who were younger, unmarried, race/ethnic minorities, with combat exposure and disabilities were at greater risk for a host of psychosocial problems, such as homelessness, SUDs, and mental illness. Veterans in these categories may require particular attention to address health disparities within the clinical population of veterans with MS.

Supplementary material

The supplementary material for this article can be found at http://doi.org/10.1017/S1092852924002165.

Author contribution

Conceptualization: J.T., S.L.S.; Funding acquisition: J.T.; Methodology: J.T., H.B., S.L.S.; Resources: J.T.; Writing – review & editing: J.T., H.B.; Data curation: H.B.; Formal analysis: H.B.; Investigation: H.B.; Writing – original draft: S.L.S.

Competing interest

S. Silveira, H. Beydoun, and J. Tsai report no conflicts of interest with this work.

Funding

There was no specific funding for this work, but this work was supported by the U.S. Department of Veterans Affairs National Center on Homelessness among Veterans.

References

Abdel Magid, HS, Jin, S, Culpepper, WJ, Nelson, LM, Wallin, M. Telemedicine utilization among patients with multiple sclerosis in the US veterans health administration, 2010–2020. Neurol Clin Pract. 2022;12(6):e133–e142. doi:10.1212/cpj.0000000000200078CrossRefGoogle ScholarPubMed
Abdollahpour, I, Nedjat, S, Mansournia, MA, Eckert, S, Weinstock-Guttman, B. Stress-full life events and multiple sclerosis: A population-based incident case-control study. Mult Scler Relat Disord. 2018;26:168–172. doi:10.1016/j.msard.2018.09.026CrossRefGoogle ScholarPubMed
Hoang, PD, Cameron, MH, Gandevia, SC, Lord, SR. Neuropsychological, balance, and mobility risk factors for falls in people with multiple sclerosis: a prospective cohort study. Arch Phys Med Rehabil. 2014;95(3):480–486. doi:10.1016/j.apmr.2013.09.017CrossRefGoogle ScholarPubMed
Hong, Y, Tang, HR, Ma, M, Chen, N, Xie, X, He, L. Multiple sclerosis and stroke: a systematic review and meta-analysis. BMC Neurol. 2019;19(1):139. doi:10.1186/s12883-019-1366-7CrossRefGoogle ScholarPubMed
Wallin, MT, Culpepper, WJ, Campbell, JD, et al. The prevalence of MS in the United States: a population-based estimate using health claims data. Neurology. 2019;92(10):e1029–e1040.CrossRefGoogle ScholarPubMed
LaVela, SL, Prohaska, TR, Furner, S, Weaver, FM. Preventive healthcare use among males with multiple sclerosis. Public Health. 2012;126(10):896–903. doi:10.1016/j.puhe.2012.06.002CrossRefGoogle ScholarPubMed
Mazumder, R, Murchison, C, Bourdette, D, Cameron, M. Falls in people with multiple sclerosis compared with falls in healthy controls. PLoS One. 2014;9(9):e107620. doi:10.1371/journal.pone.0107620CrossRefGoogle ScholarPubMed
Bergmann, C, Becker, S, Watts, A, et al. Multiple sclerosis and quality of life: the role of cognitive impairment on quality of life in people with multiple sclerosis. Mult Scler Relat Disord. 2023;79:104966. doi:10.1016/j.msard.2023.104966CrossRefGoogle ScholarPubMed
Lo, AC, Hadjimichael, O, Vollmer, TL. Treatment patterns of multiple sclerosis patients: a comparison of veterans and non-veterans using the NARCOMS registry. Mult Scler. 2005;11(1):33–40. doi:10.1191/1352458505ms1136oaCrossRefGoogle ScholarPubMed
Nelson, RE, Xie, Y, DuVall, SL, et al. Multiple sclerosis and risk of infection-related hospitalization and death in US veterans. Int J MS Care. 2015;17(5):221–230. doi:10.7224/1537-2073.2014-035CrossRefGoogle ScholarPubMed
Kurtzke, JF. Some contributions of the department of veterans affairs to the epidemiology of multiple sclerosis. Mult Scler. 2008;14(8):1007–1012. doi:10.1177/1352458508096005CrossRefGoogle Scholar
Lavela, SL, Prohaska, TR, Furner, S, Weaver, FM. Chronic diseases in male veterans with multiple sclerosis. Prev Chronic Dis. 2012;9:E55.Google ScholarPubMed
Bambara, JK, Turner, AP, Williams, RM, Haselkorn, JK. Social support and depressive symptoms among caregivers of veterans with multiple sclerosis. Rehabil Psychol. 2014;59(2):230–235. doi:10.1037/a0036312CrossRefGoogle ScholarPubMed
Coughlin, SS, Sher, L. Suicidal behavior and neurological illnesses. J Depress Anxiety. 2013;9(1):12443. doi:10.4172/2167-1044.S9-001Google Scholar
Howard, I, Turner, R, Olkin, R, Mohr, DC. Therapeutic alliance mediates the relationship between interpersonal problems and depression outcome in a cohort of multiple sclerosis patients. J Clin Psychol. 2006;62(9):1197–1204. doi:10.1002/jclp.20274CrossRefGoogle Scholar
Kojima, G, Tamai, A, Karino, S, et al. Bupropion-related visual hallucinations in a veteran with posttraumatic stress disorder and multiple sclerosis. J Clin Psychopharmacol. 2013;33(5):717–719. doi:10.1097/JCP.0b013e3182a11622CrossRefGoogle Scholar
Lee, A, Nathan, KI. Understanding psychosis in a veteran with a history of combat and multiple sclerosis. Fed Pract. 2019;36(Suppl 4):S32–S35.Google Scholar
Turner, AP, Arewasikporn, A, Hawkins, EJ, et al. Risk factors for chronic prescription opioid use in multiple sclerosis. Arch Phys Med Rehabil. 2023;104(11):1850–1856. doi:10.1016/j.apmr.2023.04.012CrossRefGoogle ScholarPubMed
Turner, AP, Williams, RM, Bowen, JD, Kivlahan, DR, Haselkorn, JK. Suicidal ideation in multiple sclerosis. Arch Phys Med Rehabil. 2006;87(8):1073–1078. doi:10.1016/j.apmr.2006.04.021CrossRefGoogle ScholarPubMed
Edens, EL, Kasprow, W, Tsai, J, Rosenheck, RA. Association of substance use and VA service-connected disability benefits with risk of homelessness among veterans. Am J Addict. 2011;20(5):412–419.CrossRefGoogle ScholarPubMed
Tsai, J, Rosenheck, RA, Kane, V. Homeless female U.S. veterans in a national supported housing program: comparison of individual characteristics and outcomes with male veterans. Psychol Serv. 2014;11(3):309–316. doi:10.1037/a0036323CrossRefGoogle Scholar
Tsai, J, Pietrzak, RH, Szymkowiak, D. The problem of veteran homelessness: an update for the new decade. Am J Prev Med. 2021;60(6):774–780. doi:10.1016/j.amepre.2020.12.012CrossRefGoogle ScholarPubMed
Fargo, JD, Brignone, E, Metraux, S, et al. Homelessness following disability-related discharges from active duty military service in Afghanistan and Iraq. Disability and Health Journal. 2017;10(4):592–599. doi:https://doi.org/10.1016/j.dhjo.2017.03.003CrossRefGoogle ScholarPubMed
Tsai, J, Rosenheck, RA. Risk factors for homelessness among US veterans. Epidemiol Rev. 2015;37(1):177–195. doi:10.1093/epirev/mxu004CrossRefGoogle ScholarPubMed
Tsai, J, Kasprow, WJ, Rosenheck, RA. Latent homeless risk profiles of a national sample of homeless veterans and their relation to program referral and admission patterns. Am J Public Health. 2013;103(Suppl 2):S239–S247. doi:10.2105/ajph.2013.301322CrossRefGoogle ScholarPubMed
Ferguson, JM, Wray, CM, Jacobs, J, et al. Variation in initial and continued use of primary, mental health, and specialty video care among veterans. Health Serv Res. 2023;58(2):402–414. doi:10.1111/1475-6773.14098CrossRefGoogle ScholarPubMed
Jones, AL, Gordon, AJ, Gabrielian, SE, et al. Perceptions of care coordination among homeless veterans receiving medical care in the veterans health administration and community care settings: results from a national survey. Med Care. 2021;59(6):504–512. doi:10.1097/MLR.0000000000001547CrossRefGoogle ScholarPubMed
Swankoski, KE, Reddy, A, Grembowski, D, Chang, ET, Wong, ES. Intensive care management for high-risk veterans in a patient-centered medical home - do some veterans benefit more than others? Healthc (Amst). 2023;11(2):100677. doi:10.1016/j.hjdsi.2023.100677CrossRefGoogle Scholar
Mitra, A, Pradhan, R, Melamed, RD, et al. Associations between natural language processing-enriched social determinants of health and suicide death among US veterans. JAMA Netw Open. 2023;6(3):e233079. doi:10.1001/jamanetworkopen.2023.3079CrossRefGoogle ScholarPubMed
Laliberte, AZ, Salvi, A, Hooker, E, et al. Factors associated with a lack of health care utilization among veterans after a positive suicide screen in the emergency department. Acad Emerg Med. 2023;30(4):321–330. doi:10.1111/acem.14695CrossRefGoogle ScholarPubMed
Kamdar, N, Hundt, NE, Ramsey, DJ, et al. Characteristics associated with persistent versus transient food insecurity among US veterans screened in the veterans health administration. J Acad Nutr Diet. 2023;123(7):1044–1052 e5. doi:10.1016/j.jand.2023.03.006CrossRefGoogle ScholarPubMed
Holliday, R, Smith, AA, Kinney, AR, et al. Research letter: traumatic brain injury among veterans accessing VA justice-related services. J Head Trauma Rehabil. 2023;38(2):184–190. doi:10.1097/HTR.0000000000000822Google ScholarPubMed
Bagnato, F, Wallin, M. COVID-19 vaccine in veterans with multiple sclerosis: protect the vulnerable. Fed Pract. 2021;38(Suppl 1):S28–S32. doi:10.12788/fp.0113Google ScholarPubMed
Barth, SK, Kang, HK, Bullman, TA, Wallin, MT. Neurological mortality among U.S. veterans of the Persian gulf war: 13-year follow-up. Am J Ind Med. 2009;52(9):663–670. doi:10.1002/ajim.20718CrossRefGoogle ScholarPubMed
Finkelstein, J, Cha, E, Wood, J, Wallin, MT. Predictors of successful acceptance of home telemanagement in veterans with multiple sclerosis. Annu Int Conf IEEE Eng Med Biol Soc. 2013;2013:7314–7317. doi:10.1109/embc.2013.6611247Google ScholarPubMed
Fuchs, TA, Wattengel, BA, Carter, MT, El-Solh, AA, Lesse, AJ, Mergenhagen, KA. Outcomes of multiple sclerosis patients admitted with COVID-19 in a large veteran cohort. Mult Scler Relat Disord. 2022;64:103964. doi:10.1016/j.msard.2022.103964CrossRefGoogle Scholar
Keszler, P, Maloni, H, Miles, Z, Jin, S, Wallin, M. Telemedicine and multiple sclerosis: a survey of health care providers before and during the COVID-19 pandemic. Int J MS Care. 2022;24(6):266–270. doi:10.7224/1537-2073.2021-103CrossRefGoogle ScholarPubMed
Khurana, SR, Bamer, AM, Turner, AP, et al. The prevalence of overweight and obesity in veterans with multiple sclerosis. Am J Phys Med Rehabil. 2009;88(2):83–91. doi:10.1097/PHM.0b013e318194f8b5CrossRefGoogle ScholarPubMed
Rinker, JR 2nd, Cossey, TC, Cutter, GR, Culpepper, WJ. A retrospective review of lithium usage in veterans with multiple sclerosis. Mult Scler Relat Disord. 2013;2(4):327–333. doi:10.1016/j.msard.2013.03.004CrossRefGoogle ScholarPubMed
Titcomb, TJ, Bao, W, Du, Y, Liu, B, Snetselaar, LG, Wahls, TL. Association of multiple sclerosis with risk of mortality among a nationally representative sample of adults in the United States. Mult Scler J Exp Transl Clin. 2022;8(2):20552173221104009. doi:10.1177/20552173221104009Google ScholarPubMed
Wallin, MT, Culpepper, WJ, Coffman, P, et al. The Gulf War era multiple sclerosis cohort: age and incidence rates by race, sex and service. Brain. 2012;135(Pt 6):1778–1785. doi:10.1093/brain/aws099CrossRefGoogle ScholarPubMed
Tsai, J, Szymkowiak, D, Jutkowitz, E. Developing an operational definition of housing instability and homelessness in Veterans Health Administration’s medical records. PLoS One. 2022;17(12):e0279973. doi:10.1371/journal.pone.0279973CrossRefGoogle ScholarPubMed
Sundararajan, V, Henderson, T, Perry, C, Muggivan, A, Quan, H, Ghali, WA. New ICD-10 version of the Charlson comorbidity index predicted in-hospital mortality. J Clin Epidemiol. 2004;57(12):1288–1294. doi:10.1016/j.jclinepi.2004.03.012CrossRefGoogle ScholarPubMed
Marrie, RA, Reingold, S, Cohen, J, et al. The incidence and prevalence of psychiatric disorders in multiple sclerosis: A systematic review. Mult Scler J. 2015;21(3):305–317. doi:10.1177/1352458514564487CrossRefGoogle ScholarPubMed
Inanc, Y, Kaya, T. Psychiatric disorders in multiple sclerosis. J Mult Scler Res. 2022;2(2):31–35. doi:10.4274/jmsr.galenos.2022.2022-8-1Google Scholar
Marrie, RA, Walld, R, Bolton, JM, et al. Effect of mood and anxiety disorders on health care utilization in multiple sclerosis. Mult Scler J. 2021;27(9):1411–1420. doi:10.1177/1352458520963880CrossRefGoogle ScholarPubMed
Gupta, S, Fellows, K, Weinstock-Guttman, B, Hagemeier, J, Zivadinov, R, Ramanathan, M. Marijuana use by patients with multiple sclerosis. Int J MS Care. 2019;21(2):57–62. doi:10.7224/1537-2073.2017-112CrossRefGoogle ScholarPubMed
Sandbrink, F, Murphy, JL, Johansson, M, et al. The use of opioids in the management of chronic pain: synopsis of the 2022 updated U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guideline. Ann Intern Med. 2023;176(3):388–397. doi:10.7326/m22-2917CrossRefGoogle ScholarPubMed
Fusaro, VA, Levy, HG, Shaefer, HL. Racial and ethnic disparities in the lifetime prevalence of homelessness in the United States. Demography. 2018;55(6):2119–2128. doi:10.1007/s13524-018-0717-0CrossRefGoogle ScholarPubMed
Montgomery, AE, Szymkowiak, D, Tsai, J. Housing instability and homeless program use among veterans: the intersection of race, sex, and homelessness. Hous Policy Debate. 2020;30(3):396–408. doi:10.1080/10511482.2020.1712613CrossRefGoogle Scholar
Amezcua, L, Rivera, VM, Vazquez, TC, Baezconde-Garbanati, L, Langer-Gould, A. Health disparities, inequities, and social determinants of health in multiple sclerosis and related disorders in the US: a review. JAMA Neurol. 2021;78(12):1515–1524.CrossRefGoogle Scholar
Figure 0

Figure 1. Study flowchart.

Figure 1

Table 1. Sociodemographic and Clinical Characteristics of U.S. Veterans Diagnosed with Multiple Sclerosis (MS) and Propensity-Score-Matched U.S. Veterans Not Diagnosed with MS—Veterans Health Administration (January 1, 2022-December 31, 2022)

Figure 2

Figure 2. Prevalence (95% confidence interval) of homelessness, substance use disorders, and mental illness, among U.S. veterans diagnosed with multiple sclerosis and propensity-score-matched U.S. veterans not diagnosed with multiple sclerosis—Veterans Health Administration (January 1, 2022–December 22, 2022)

Figure 3

Table 2. Differences in Prevalence of Homelessness, Substance Use Disorders, and Mental Illnesses between U.S. Veterans Diagnosed with Multiple Sclerosis (MS) and Propensity-Score-Matched U.S. Veterans Not Diagnosed with MS—Veterans Health Administration (January 1, 2022-December 31, 2022)

Figure 4

Table 3. Multiple Logistic Regression Models for Sociodemographic and Clinical Correlates of Prevalent Homelessness, Substance Use Disorder, and Mental Illness, among U.S. Veterans Diagnosed with Multiple Sclerosis (MS)—Veterans Health Administration (January 1, 2022–December 31, 2022)

Supplementary material: File

Silveira et al. supplementary material

Silveira et al. supplementary material
Download Silveira et al. supplementary material(File)
File 14.3 KB